Table of Content

1 Capsule-based Inhalers Market Overview
1.1 Product Overview and Scope of Capsule-based Inhalers
1.2 Capsule-based Inhalers Segment by Type
1.2.1 Global Capsule-based Inhalers Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Gelatin Capsules
1.2.3 Hypromellose Capsules
1.3 Capsule-based Inhalers Segment by Application
1.3.1 Capsule-based Inhalers Sales Comparison by Application: (2021-2027)
1.3.2 Asthma
1.3.3 COPD (Chronic Obstructive Pulmonary Disease)
1.4 Global Capsule-based Inhalers Market Size Estimates and Forecasts
1.4.1 Global Capsule-based Inhalers Revenue 2016-2027
1.4.2 Global Capsule-based Inhalers Sales 2016-2027
1.4.3 Capsule-based Inhalers Market Size by Region: 2016 Versus 2021 Versus 2027

2 Capsule-based Inhalers Market Competition by Manufacturers
2.1 Global Capsule-based Inhalers Sales Market Share by Manufacturers (2016-2021)
2.2 Global Capsule-based Inhalers Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Capsule-based Inhalers Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Capsule-based Inhalers Manufacturing Sites, Area Served, Product Type
2.5 Capsule-based Inhalers Market Competitive Situation and Trends
2.5.1 Capsule-based Inhalers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Capsule-based Inhalers Players Market Share by Revenue
2.5.3 Global Capsule-based Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Capsule-based Inhalers Retrospective Market Scenario by Region
3.1 Global Capsule-based Inhalers Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Capsule-based Inhalers Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Capsule-based Inhalers Market Facts & Figures by Country
3.3.1 North America Capsule-based Inhalers Sales by Country
3.3.2 North America Capsule-based Inhalers Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Capsule-based Inhalers Market Facts & Figures by Country
3.4.1 Europe Capsule-based Inhalers Sales by Country
3.4.2 Europe Capsule-based Inhalers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Capsule-based Inhalers Market Facts & Figures by Region
3.5.1 Asia Pacific Capsule-based Inhalers Sales by Region
3.5.2 Asia Pacific Capsule-based Inhalers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Capsule-based Inhalers Market Facts & Figures by Country
3.6.1 Latin America Capsule-based Inhalers Sales by Country
3.6.2 Latin America Capsule-based Inhalers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Capsule-based Inhalers Market Facts & Figures by Country
3.7.1 Middle East and Africa Capsule-based Inhalers Sales by Country
3.7.2 Middle East and Africa Capsule-based Inhalers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Capsule-based Inhalers Historic Market Analysis by Type
4.1 Global Capsule-based Inhalers Sales Market Share by Type (2016-2021)
4.2 Global Capsule-based Inhalers Revenue Market Share by Type (2016-2021)
4.3 Global Capsule-based Inhalers Price by Type (2016-2021)

5 Global Capsule-based Inhalers Historic Market Analysis by Application
5.1 Global Capsule-based Inhalers Sales Market Share by Application (2016-2021)
5.2 Global Capsule-based Inhalers Revenue Market Share by Application (2016-2021)
5.3 Global Capsule-based Inhalers Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hovione
6.1.1 Hovione Corporation Information
6.1.2 Hovione Description and Business Overview
6.1.3 Hovione Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hovione Product Portfolio
6.1.5 Hovione Recent Developments/Updates
6.2 Iconovo AB
6.2.1 Iconovo AB Corporation Information
6.2.2 Iconovo AB Description and Business Overview
6.2.3 Iconovo AB Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Iconovo AB Product Portfolio
6.2.5 Iconovo AB Recent Developments/Updates
6.3 Inbrija
6.3.1 Inbrija Corporation Information
6.3.2 Inbrija Description and Business Overview
6.3.3 Inbrija Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Inbrija Product Portfolio
6.3.5 Inbrija Recent Developments/Updates
6.4 Utibron Neohaler (Novartis AG)
6.4.1 Utibron Neohaler (Novartis AG) Corporation Information
6.4.2 Utibron Neohaler (Novartis AG) Description and Business Overview
6.4.3 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Utibron Neohaler (Novartis AG) Product Portfolio
6.4.5 Utibron Neohaler (Novartis AG) Recent Developments/Updates
6.5 Zibo Laixu Medical Equipment
6.5.1 Zibo Laixu Medical Equipment Corporation Information
6.5.2 Zibo Laixu Medical Equipment Description and Business Overview
6.5.3 Zibo Laixu Medical Equipment Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Zibo Laixu Medical Equipment Product Portfolio
6.5.5 Zibo Laixu Medical Equipment Recent Developments/Updates

7 Capsule-based Inhalers Manufacturing Cost Analysis
7.1 Capsule-based Inhalers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Capsule-based Inhalers
7.4 Capsule-based Inhalers Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Capsule-based Inhalers Distributors List
8.3 Capsule-based Inhalers Customers

9 Capsule-based Inhalers Market Dynamics
9.1 Capsule-based Inhalers Industry Trends
9.2 Capsule-based Inhalers Growth Drivers
9.3 Capsule-based Inhalers Market Challenges
9.4 Capsule-based Inhalers Market Restraints

10 Global Market Forecast
10.1 Capsule-based Inhalers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Capsule-based Inhalers by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Capsule-based Inhalers by Type (2022-2027)
10.2 Capsule-based Inhalers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Capsule-based Inhalers by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Capsule-based Inhalers by Application (2022-2027)
10.3 Capsule-based Inhalers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Capsule-based Inhalers by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Capsule-based Inhalers by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Capsule-based Inhalers Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Capsule-based Inhalers Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Capsule-based Inhalers Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Capsule-based Inhalers Covered in This Study
Table 5. Global Capsule-based Inhalers Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Capsule-based Inhalers Sales Share by Manufacturers (2016-2021)
Table 7. Global Capsule-based Inhalers Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Capsule-based Inhalers Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Capsule-based Inhalers Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Capsule-based Inhalers Manufacturing Sites and Area Served
Table 11. Manufacturers Capsule-based Inhalers Product Type
Table 12. Global Capsule-based Inhalers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Capsule-based Inhalers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Capsule-based Inhalers as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Capsule-based Inhalers Sales by Region (2016-2021) & (K Units)
Table 16. Global Capsule-based Inhalers Sales Market Share by Region (2016-2021)
Table 17. Global Capsule-based Inhalers Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Capsule-based Inhalers Sales by Country (2016-2021) & (K Units)
Table 19. North America Capsule-based Inhalers Sales Market Share by Country (2016-2021)
Table 20. North America Capsule-based Inhalers Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Capsule-based Inhalers Revenue Market Share by Country (2016-2021)
Table 22. Europe Capsule-based Inhalers Sales by Country (2016-2021) & (K Units)
Table 23. Europe Capsule-based Inhalers Sales Market Share by Country (2016-2021)
Table 24. Europe Capsule-based Inhalers Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Capsule-based Inhalers Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Capsule-based Inhalers Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Capsule-based Inhalers Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Capsule-based Inhalers Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Capsule-based Inhalers Revenue Market Share by Region (2016-2021)
Table 30. Latin America Capsule-based Inhalers Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Capsule-based Inhalers Sales Market Share by Country (2016-2021)
Table 32. Latin America Capsule-based Inhalers Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Capsule-based Inhalers Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Capsule-based Inhalers Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Capsule-based Inhalers Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Capsule-based Inhalers Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Capsule-based Inhalers Revenue Market Share by Country (2016-2021)
Table 38. Global Capsule-based Inhalers Sales (K Units) by Type (2016-2021)
Table 39. Global Capsule-based Inhalers Sales Market Share by Type (2016-2021)
Table 40. Global Capsule-based Inhalers Revenue (Million US$) by Type (2016-2021)
Table 41. Global Capsule-based Inhalers Revenue Share by Type (2016-2021)
Table 42. Global Capsule-based Inhalers Price (USD/Unit) by Type (2016-2021)
Table 43. Global Capsule-based Inhalers Sales (K Units) by Application (2016-2021)
Table 44. Global Capsule-based Inhalers Sales Market Share by Application (2016-2021)
Table 45. Global Capsule-based Inhalers Revenue (Million US$) by Application (2016-2021)
Table 46. Global Capsule-based Inhalers Revenue Share by Application (2016-2021)
Table 47. Global Capsule-based Inhalers Price (USD/Unit) by Application (2016-2021)
Table 48. Hovione Corporation Information
Table 49. Hovione Description and Business Overview
Table 50. Hovione Capsule-based Inhalers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Hovione Capsule-based Inhalers Product
Table 52. Hovione Recent Developments/Updates
Table 53. Iconovo AB Corporation Information
Table 54. Iconovo AB Description and Business Overview
Table 55. Iconovo AB Capsule-based Inhalers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Iconovo AB Capsule-based Inhalers Product
Table 57. Iconovo AB Recent Developments/Updates
Table 58. Inbrija Corporation Information
Table 59. Inbrija Description and Business Overview
Table 60. Inbrija Capsule-based Inhalers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Inbrija Capsule-based Inhalers Product
Table 62. Inbrija Recent Developments/Updates
Table 63. Utibron Neohaler (Novartis AG) Corporation Information
Table 64. Utibron Neohaler (Novartis AG) Description and Business Overview
Table 65. Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Utibron Neohaler (Novartis AG) Capsule-based Inhalers Product
Table 67. Utibron Neohaler (Novartis AG) Recent Developments/Updates
Table 68. Zibo Laixu Medical Equipment Corporation Information
Table 69. Zibo Laixu Medical Equipment Description and Business Overview
Table 70. Zibo Laixu Medical Equipment Capsule-based Inhalers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Zibo Laixu Medical Equipment Capsule-based Inhalers Product
Table 72. Zibo Laixu Medical Equipment Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Capsule-based Inhalers Distributors List
Table 76. Capsule-based Inhalers Customers List
Table 77. Capsule-based Inhalers Market Trends
Table 78. Capsule-based Inhalers Growth Drivers
Table 79. Capsule-based Inhalers Market Restraints
Table 80. Global Capsule-based Inhalers Sales Forecast by Type (2022-2027) & (K Units)
Table 81. Global Capsule-based Inhalers Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Capsule-based Inhalers Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Capsule-based Inhalers Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Capsule-based Inhalers Sales Forecast by Application (2022-2027) & (K Units)
Table 85. Global Capsule-based Inhalers Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Capsule-based Inhalers Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Capsule-based Inhalers Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Capsule-based Inhalers Sales Forecast by Region (2022-2027) & (K Units)
Table 89. Global Capsule-based Inhalers Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Capsule-based Inhalers Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Capsule-based Inhalers Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Capsule-based Inhalers
Figure 2. Global Capsule-based Inhalers Market Share by Type in 2020 & 2027
Figure 3. Gelatin Capsules Product Picture
Figure 4. Hypromellose Capsules Product Picture
Figure 5. Global Capsule-based Inhalers Market Share by Application in 2020 & 2027
Figure 6. Asthma
Figure 7. COPD (Chronic Obstructive Pulmonary Disease)
Figure 8. Global Capsule-based Inhalers Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Capsule-based Inhalers Market Size 2016-2027 (US$ Million)
Figure 10. Global Capsule-based Inhalers Sales 2016-2027 (K Units)
Figure 11. Global Capsule-based Inhalers Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Capsule-based Inhalers Sales Share by Manufacturers in 2020
Figure 13. Global Capsule-based Inhalers Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Capsule-based Inhalers Players: Market Share by Revenue in 2020
Figure 15. Capsule-based Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Capsule-based Inhalers Sales Market Share by Region (2016-2021)
Figure 17. Global Capsule-based Inhalers Sales Market Share by Region in 2020
Figure 18. Global Capsule-based Inhalers Revenue Market Share by Region (2016-2021)
Figure 19. Global Capsule-based Inhalers Revenue Market Share by Region in 2020
Figure 20. U.S. Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Capsule-based Inhalers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Capsule-based Inhalers by Type (2016-2021)
Figure 45. Sales Market Share of Capsule-based Inhalers by Application (2016-2021)
Figure 46. Sales Market Share of Capsule-based Inhalers by Application in 2020
Figure 47. Revenue Share of Capsule-based Inhalers by Application (2016-2021)
Figure 48. Revenue Share of Capsule-based Inhalers by Application in 2020
Figure 49. Manufacturing Cost Structure of Capsule-based Inhalers
Figure 50. Manufacturing Process Analysis of Capsule-based Inhalers
Figure 51. Capsule-based Inhalers Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed